Literature DB >> 17696253

Lithocholic acid induction of the FGF19 promoter in intestinal cells is mediated by PXR.

Wolfgang Wistuba1, Carsten Gnewuch, Gerhard Liebisch, Gerd Schmitz, Thomas Langmann.   

Abstract

AIM: To study the effect of the toxic secondary bile acid lithocholic acid (LCA) on the expression of fibroblast growth factor 19 (FGF19) in intestinal cells and to characterize the pregnane-X-receptor (PXR) response of the FGF19 promoter region.
METHODS: The intestinal cell line LS174T was stimulated with various concentrations of chenodeoxy-cholic acid and lithocholic acid for several time points. FGF19 mRNA levels were determined with quantitative realtime RT-PCR. FGF19 deletion promoter constructs were generated and the LCA response was analzyed in reporter assays. Co-transfections with PXR and RXR were carried out to study FGF19 regulation by these factors.
RESULTS: LCA and CDCA strongly up-regulate FGF19 mRNA expression in LS174T cells in a time and dose dependent manner. Using reporter gene assays with several deletion constructs we found that the LCA responsive element in the human FGF19 promoter maps to the proximal regulatory region containing two potential binding sites for PXR. Overexpression of PXR and its dimerization partner retinoid X receptor (RXR) and stimulation with LCA or the potent PXR ligand rifampicin leads to a significant induction of FGF19 promoter activity in intestinal cells.
CONCLUSION: LCA induced feedback inhibition of bile acid synthesis in the liver is likely to be regulated by PXR inducing intestinal FGF19 expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17696253      PMCID: PMC4250623          DOI: 10.3748/wjg.v13.i31.4230

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

1.  NUBIScan, an in silico approach for prediction of nuclear receptor response elements.

Authors:  Michael Podvinec; Michel R Kaufmann; Christoph Handschin; Urs A Meyer
Journal:  Mol Endocrinol       Date:  2002-06

2.  Loss of detoxification in inflammatory bowel disease.

Authors:  Thomas Langmann; Gerd Schmitz
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2006-07

3.  Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression.

Authors:  Yatrik M Shah; Xiaochao Ma; Keiichirou Morimura; Insook Kim; Frank J Gonzalez
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-12-14       Impact factor: 4.052

4.  The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module.

Authors:  B Goodwin; E Hodgson; C Liddle
Journal:  Mol Pharmacol       Date:  1999-12       Impact factor: 4.436

5.  Endogenous bile acids are ligands for the nuclear receptor FXR/BAR.

Authors:  H Wang; J Chen; K Hollister; L C Sowers; B M Forman
Journal:  Mol Cell       Date:  1999-05       Impact factor: 17.970

6.  Identification of a nuclear receptor for bile acids.

Authors:  M Makishima; A Y Okamoto; J J Repa; H Tu; R M Learned; A Luk; M V Hull; K D Lustig; D J Mangelsdorf; B Shan
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

7.  A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis.

Authors:  B Goodwin; S A Jones; R R Price; M A Watson; D D McKee; L B Moore; C Galardi; J G Wilson; M C Lewis; M E Roth; P R Maloney; T M Willson; S A Kliewer
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

8.  Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors.

Authors:  T T Lu; M Makishima; J J Repa; K Schoonjans; T A Kerr; J Auwerx; D J Mangelsdorf
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

9.  Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation.

Authors:  Changcheng Zhou; Michelle M Tabb; Edward L Nelson; Felix Grün; Suman Verma; Asal Sadatrafiei; Min Lin; Shyamali Mallick; Barry M Forman; Kenneth E Thummel; Bruce Blumberg
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

10.  Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues.

Authors:  Thomas Langmann; Richard Mauerer; Alexandra Zahn; Christoph Moehle; Mario Probst; Wolfgang Stremmel; Gerd Schmitz
Journal:  Clin Chem       Date:  2003-02       Impact factor: 8.327

View more
  21 in total

1.  Upregulation of hepatic bile acid synthesis via fibroblast growth factor 19 is defective in gallstone disease but functional in overweight individuals.

Authors:  Olga Renner; Simone Harsch; Silke Matysik; Dieter Lütjohann; Gerd Schmitz; Eduard F Stange
Journal:  United European Gastroenterol J       Date:  2014-06       Impact factor: 4.623

Review 2.  Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.

Authors:  Chiara Degirolamo; Carlo Sabbà; Antonio Moschetta
Journal:  Nat Rev Drug Discov       Date:  2015-11-16       Impact factor: 84.694

3.  Pharmacological Activation of PXR and CAR Downregulates Distinct Bile Acid-Metabolizing Intestinal Bacteria and Alters Bile Acid Homeostasis.

Authors:  Joseph L Dempsey; Dongfang Wang; Gunseli Siginir; Qiang Fei; Daniel Raftery; Haiwei Gu; Julia Yue Cui
Journal:  Toxicol Sci       Date:  2019-03-01       Impact factor: 4.849

4.  Bile Acid Receptors and Gastrointestinal Functions.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Liver Res       Date:  2019-01-14

5.  Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH.

Authors:  Gabriella V Hernandez; Victoria A Smith; Megan Melnyk; Matthew A Burd; Kimberly A Sprayberry; Mark S Edwards; Daniel G Peterson; Darin C Bennet; Rob K Fanter; Daniel A Columbus; Juan P Steibel; Hunter Glanz; Chad Immoos; Margaret S Rice; Tasha M Santiago-Rodriguez; Jason Blank; Jennifer J VanderKelen; Christopher L Kitts; Brian D Piccolo; Michael R La Frano; Douglas G Burrin; Magdalena Maj; Rodrigo Manjarin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-31       Impact factor: 4.052

6.  Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice.

Authors:  Hongwei Wang; Madhukumar Venkatesh; Hao Li; Regina Goetz; Subhajit Mukherjee; Arunima Biswas; Liang Zhu; Andreas Kaubisch; Lei Wang; James Pullman; Kathleen Whitney; Makoto Kuro-o; Andres I Roig; Jerry W Shay; Moosa Mohammadi; Sridhar Mani
Journal:  J Clin Invest       Date:  2011-07-11       Impact factor: 14.808

7.  Rifampicin, not vitamin E, suppresses parenteral nutrition-associated liver disease development through the pregnane X receptor pathway in piglets.

Authors:  Gregory Guthrie; Barbara Stoll; Shaji Chacko; Charlotte Lauridsen; Jogchum Plat; Douglas Burrin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-10-11       Impact factor: 4.052

Review 8.  Nuclear receptors and nonalcoholic fatty liver disease.

Authors:  Matthew C Cave; Heather B Clair; Josiah E Hardesty; K Cameron Falkner; Wenke Feng; Barbara J Clark; Jennifer Sidey; Hongxue Shi; Bashar A Aqel; Craig J McClain; Russell A Prough
Journal:  Biochim Biophys Acta       Date:  2016-03-04

Review 9.  Nuclear receptors in bile acid metabolism.

Authors:  Tiangang Li; John Y L Chiang
Journal:  Drug Metab Rev       Date:  2013-02       Impact factor: 4.518

Review 10.  Bile Acid Metabolism and Signaling in Cholestasis, Inflammation, and Cancer.

Authors:  Tiangang Li; Udayan Apte
Journal:  Adv Pharmacol       Date:  2015-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.